Related references
Note: Only part of the references are listed.Gene polymorphisms in antioxidant enzymes correlate with the efficacy of androgen-deprivation therapy for prostate cancer with implications of oxidative stress
M. Shiota et al.
ANNALS OF ONCOLOGY (2017)
EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
Marko Babjuk et al.
EUROPEAN UROLOGY (2017)
Phenotypic Spectrum in Osteogenesis Imperfecta Due to Mutations in TMEM38B: Unraveling a Complex Cellular Defect
Emma A. Webb et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma
Ashish M. Kamat et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
10 Years of GWAS Discovery: Biology, Function, and Translation
Peter M. Visscher et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2017)
A review on the evolution of PD-1/PD-L1 immunotherapy for bladder cancer: The future is now
Joaquin Bellmunt et al.
CANCER TREATMENT REVIEWS (2017)
Definitions, End Points, and Clinical Trial Designs for Non-Muscle-Invasive Bladder Cancer: Recommendations From the International Bladder Cancer Group
Ashish M. Kamat et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Potential Role for YB-1 in Castration-Resistant Prostate Cancer and Resistance to Enzalutamide Through the Androgen Receptor V7
Masaki Shiota et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
MPP2 is a postsynaptic MAGUK scaffold protein that links SynCAM1 cell adhesion molecules to core components of the postsynaptic density
Nils Rademacher et al.
SCIENTIFIC REPORTS (2016)
Prediction of Bacillus Calmette-Guerin Response in Patients with Bladder Cancer after Transurethral Resection of Bladder Tumor by Using Genetic Variation Based on Genomic Studies
Ning Zhang et al.
BIOMED RESEARCH INTERNATIONAL (2016)
Potential Role for YB-1 in Castration-Resistant Prostate Cancer and Resistance to Enzalutamide Through the Androgen Receptor V7
Masaki Shiota et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
The role of functional polymorphisms in immune response genes as biomarkers of bacille Calmette-Guerin (BCG) immunotherapy outcome in bladder cancer: establishment of a predictive profile in a Southern Europe population
Luis Lima et al.
BJU INTERNATIONAL (2015)
Japonica array: improved genotype imputation by designing a population-specific SNP array with 1070 Japanese individuals
Yosuke Kawai et al.
JOURNAL OF HUMAN GENETICS (2015)
Outcome after BCG treatment for urinary bladder cancer may be influenced by polymorphisms in the NOS2 and NOS3 genes
Charlotta Ryk et al.
REDOX BIOLOGY (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1
Laura Fachal et al.
NATURE GENETICS (2014)
Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: Current understanding and perspectives on engineered BCG vaccine
Koji Kawai et al.
CANCER SCIENCE (2013)
STAT3 Polymorphism Can Predict the Response to Interferon-α Therapy in Patients with Metastatic Renal Cell Carcinoma
Masatoshi Eto et al.
EUROPEAN UROLOGY (2013)
TNF superfamily in inflammatory disease: translating basic insights
Michael Croft et al.
TRENDS IN IMMUNOLOGY (2012)
Predictive Biomarkers of Bacillus Calmette-Guerin Immunotherapy Response in Bladder Cancer: Where Are We Now?
Luis Lima et al.
ADVANCES IN UROLOGY (2012)
NRAMP1 and hGPX1 Gene Polymorphism and Response to Bacillus Calmette-Guerin Therapy for Bladder Cancer
Edmund Chiong et al.
EUROPEAN UROLOGY (2011)
Control of Immunity by the TNFR-Related Molecule OX40 (CD134)
Michael Croft
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Association of tumour necrosis factor-α gene (T-1031C, C-863A, and C-857T) polymorphisms with bladder cancer susceptibility and outcome after bacille Calmette-Guerin immunotherapy
Dinesh K. Ahirwar et al.
BJU INTERNATIONAL (2009)
PLINK: A tool set for whole-genome association and population-based linkage analyses
Shaun Purcell et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
STAT3 polymorphism predicts interferon-alfa response in patients with metastatic renal cell carcinoma
Noriyuki Ito et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Polymorphisms of human NRAMP1 gene are associated with response to bacillus Calmette-Guerin immunotherapy for superficial bladder cancer
M Decobert et al.
JOURNAL OF UROLOGY (2006)
Current practice in the management of superficial bladder cancer in the Netherlands and Belgian flanders: A survey
JA Witjes et al.
EUROPEAN UROLOGY (2006)
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials
RJ Sylvester et al.
EUROPEAN UROLOGY (2006)
Polymorphisms in inflammation genes and bladder cancer: From initiation to recurrence, progression, and survival
D Leibovici et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Share Paper
